Prostate Cancer and Prostatic Diseases - Does adjuvant hormonal treatment with goserelin acetate depot 3.6 mg modify 5-years disease free survival in patients with pathological ‘C ...

ZOLADEX 3.6 mg contains the active ingredient goserelin acetate. ZOLADEX 3.6 mg is used to lower the amount of sex hormones in the body. ZOLADEX 3.6 mg is used to treat breast cancer in some women ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 10.8 mg contains the active ingredient goserelin acetate ...

Pre- and perimenopausal women and men will additionally receive goserelin on day 1 of every cycle. During the treatment period participants will be required to attend a site visit approximately every ...

Zoledronic acid is effective in the prevention of bone loss in premenopausal women with breast cancer being treated with endocrine therapy. The benefit of zoledronic acid probably extends for some ...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy ...

Aussies could be left hundreds of dollars out-of-pocket as Donald Trump threatens 200 per cent tariffs on Australian pharmaceutical exports to the US unless a major medicinal subsidy scheme is ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap (leuprorelin acetate) and AstraZeneca's Zoladex (goserelin acetate) – which are ...

NICE recommends Novartis’ Kisqali® (ribociclib) for eligible HR+/HER2- early breast cancer patients at high risk of recurrence The National Institute for Health and Care Excellence (NICE) has ...

BYLieve showed activity of alpelisib plus fulvestrant with manageable toxicity in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer, after progression on a ...